Patent details

EP2692347 Title: OINTMENT WITH EXCELLENT FORMULATION STABILITY

Basic Information

Publication number:
EP2692347
PCT Application Number:
JP2012058072
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP127627917
PCT Publication Number:
WO2012133492
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
OINTMENT WITH EXCELLENT FORMULATION STABILITY
French Title of Invention:
ONGUENT PRÉSENTANT UNE EXCELLENTE STABILITÉ DE FORMULATION
German Title of Invention:
SALBE MIT HERVORRAGENDER FORMULATIONSSTABILITÄT
SPC Number:

Dates

Filing date:
28/03/2012
Grant date:
08/03/2017
EP Publication Date:
05/02/2014
PCT Publication Date:
04/10/2012
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
08/03/2017
EP B1 Publication Date:
08/03/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
28/03/2017
Expiration date:
28/03/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
08/03/2017
 
 

Name:
Maruho Co., Ltd.
Address:
5-22 Nakatsu 1-chome Kita-ku Osaka-shi, Osaka 531-0071, Japan (JP)

Name:
Mitsubishi Tanabe Pharma Corporation
Address:
3-2-10, Dosho-machi, Chuo-ku Osaka-shi, Osaka 541-8505, Japan (JP)

Inventor

1

Name:
EMI, Hidetoshi
Address:
Japan (JP)

2

Name:
SAKAGUCHI, Tomoki
Address:
Japan (JP)

Priority

Priority Number:
2011080154
Priority Date:
31/03/2011
Priority Country:
Japan (JP)

Classification

IPC classification:
A61K 9/06; A61K 31/4709; A61K 47/04; A61K 47/12; A61K 47/22; A61P 43/00; A61K 47/10; A61K 47/14; A61K 47/18;

Publication

European Patent Bulletin

Issue number:
201710
Publication date:
08/03/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
13/09/2017 Outgoing Correspondence 2